Browse
FDA applications
Approved and filed applications connected to their products and owning companies.
29,787 results
| Application | Applicant | Application number |
|---|---|---|
| NDA 209259 | SUN PHARM INDS LTD | NDA209259 |
| NDA 209260 | FRESENIUS KABI USA LLC | NDA209260 |
| NDA 209269 | EPI HEALTH LLC | NDA209269 |
| NDA 209279 | ACTELION PHARMACEUTICALS US INC | NDA209279 |
| NDA 209296 | HERON THERAPEUTICS INC | NDA209296 |
| NDA 209299 | RIGEL PHARMACEUTICALS INC | NDA209299 |
| NDA 209305 | ACLARIS THERAPEUTICS INC | NDA209305 |
| NDA 209310 | INTERSECT ENT INC | NDA209310 |
| NDA 209311 | IRONSHORE PHARMACEUTICALS INC A WHOLLY OWNED SUB OF COLLEGIUM PHARMACEUTICAL INC | NDA209311 |
| NDA 209321 | JACOBUS PHARM CO INC | NDA209321 |
| NDA 209347 | EXELA PHARMA SCIENCES LLC | NDA209347 |
| NDA 209353 | DOW PHARMACEUTICAL SCIENCES | NDA209353 |
| NDA 209354 | BAUSCH HEALTH AMERICAS INC | NDA209354 |
| NDA 209355 | BAUSCH HEALTH AMERICAS INC | NDA209355 |
| NDA 209359 | HOSPIRA INC | NDA209359 |
| NDA 209360 | LA JOLLA PHARMA LLC | NDA209360 |
| NDA 209363 | EVOFEM INC | NDA209363 |
| NDA 209376 | AMERICAN REGENT INC | NDA209376 |
| NDA 209377 | AMERICAN REGENT INC | NDA209377 |
| NDA 209379 | AMERICAN REGENT INC | NDA209379 |
| NDA 209381 | NORGINE BV | NDA209381 |
| NDA 209387 | EXELA PHARMA SCIENCES LLC | NDA209387 |
| NDA 209388 | QOL MEDICAL LLC | NDA209388 |
| NDA 209394 | ABBVIE INC | NDA209394 |
| NDA 209400 | DEXCEL PHARMA TECHNOLOGIES LTD | NDA209400 |
| NDA 209401 | JAZZ PHARMACEUTICALS THERAPEUTICS INC | NDA209401 |
| NDA 209405 | EXELTIS USA INC | NDA209405 |
| NDA 209410 | SUPERNUS PHARMACEUTICALS INC | NDA209410 |
| NDA 209445 | SHIONOGI INC | NDA209445 |
| NDA 209449 | CYCLE PHARMACEUTICALS LTD | NDA209449 |
| NDA 209463 | HIKMA PHARMACEUTICALS LLC | NDA209463 |
| NDA 209471 | AFT PHARMACEUTICALS US INC | NDA209471 |
| NDA 209472 | EAGLE PHARMACEUTICALS INC | NDA209472 |
| NDA 209478 | CMP DEVELOPMENT LLC | NDA209478 |
| NDA 209481 | MYLAN LABORATORIES LTD | NDA209481 |
| NDA 209482 | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LTD ENGLAND | NDA209482 |
| NDA 209483 | PRIMUS PHARMACEUTICALS INC | NDA209483 |
| NDA 209500 | INTRA-CELLULAR THERAPIES INC | NDA209500 |
| NDA 209501 | UPJOHN US 2 LLC | NDA209501 |
| NDA 209510 | LXO IRELAND DESIGNATED ACTIVITY CO | NDA209510 |
| NDA 209511 | INNOCOLL PHARMACEUTICALS | NDA209511 |
| NDA 209512 | ABBVIE INC | NDA209512 |
| NDA 209521 | ALMIRALL LLC | NDA209521 |
| NDA 209529 | ASTELLAS PHARMA US INC | NDA209529 |
| NDA 209531 | BIOGEN INC | NDA209531 |
| NDA 209552 | EUGIA PHARMA SPECIALITIES LTD | NDA209552 |
| NDA 209566 | MERIDIAN MEDICAL TECHNOLOGIES LLC | NDA209566 |
| NDA 209569 | DUTCH OPHTHALMIC RESEARCH CENTER INTERNATIONAL BV | NDA209569 |
| NDA 209570 | CHEMO RESEARCH SL | NDA209570 |
| NDA 209575 | OMNIVIUM PHARMACEUTICALS LLC | NDA209575 |